| Year |
Citation |
Score |
| 2020 |
Yu EW, Tsourdi E, Clarke BL, Bauer DC, Drake MT. Osteoporosis Management in the Era of COVID-19. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 32406536 DOI: 10.1002/Jbmr.4049 |
0.314 |
|
| 2020 |
Athimulam S, Delivanis D, Thomas M, Young WF, Khosla S, Drake M, Bancos I. The Impact of Mild Autonomous Cortisol Secretion on Bone Turnover Markers. The Journal of Clinical Endocrinology and Metabolism. PMID 32154561 DOI: 10.1210/Clinem/Dgaa120 |
0.337 |
|
| 2020 |
Weivoda MM, Chew CK, Monroe DG, Farr JN, Atkinson EJ, Geske JR, Eckhardt B, Thicke B, Ruan M, Tweed AJ, McCready LK, Rizza RA, Matveyenko A, Kassem M, Andersen TL, ... ... Drake MT, et al. Identification of osteoclast-osteoblast coupling factors in humans reveals links between bone and energy metabolism. Nature Communications. 11: 87. PMID 31911667 DOI: 10.1038/S41467-019-14003-6 |
0.341 |
|
| 2020 |
Samakkarnthai P, Sfeir JG, Atkinson EJ, Achenbach SJ, Tweed AJ, Volkman TL, Drake MT, Farr JN, Khosla S. SUN-LB68 Advanced Glycation Endproducts Are Associated With Worse Bone Material Strength in Older Adults With and Without Type 2 Diabetes Journal of the Endocrine Society. 4. DOI: 10.1210/Jendso/Bvaa046.2045 |
0.301 |
|
| 2019 |
Morris EV, Suchacki KJ, Hocking J, Cartwright R, Sowman A, Gamez B, Lea R, Drake MT, Cawthorn WP, Edwards CM. Myeloma cells down-regulate adiponectin in bone marrow adipocytes via TNF-alpha. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 31886918 DOI: 10.1002/Jbmr.3951 |
0.32 |
|
| 2019 |
Berent TE, Dorschner JM, Craig TA, Drake MT, Westendorf JJ, Kumar R. Lung tumor cells inhibit bone mineralization and osteoblast activity. Biochemical and Biophysical Research Communications. PMID 31537378 DOI: 10.1016/J.Bbrc.2019.09.045 |
0.327 |
|
| 2019 |
Hillengass J, Usmani S, Rajkumar SV, Durie BGM, Mateos MV, Lonial S, Joao C, Anderson KC, García-Sanz R, Serra ER, Du J, van de Donk N, Berdeja JG, Terpos E, Zamagni E, ... ... Drake M, et al. International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders. The Lancet. Oncology. 20: e302-e312. PMID 31162104 DOI: 10.1016/S1470-2045(19)30309-2 |
0.306 |
|
| 2019 |
Bedatsova L, Drake MT. The Skeletal Impact of Cancer Therapies. British Journal of Clinical Pharmacology. PMID 30723928 DOI: 10.1111/Bcp.13866 |
0.302 |
|
| 2019 |
Cremers S, Drake MT, Ebetino FH, Bilezikian JP, Russell RGG. Pharmacology of Bisphosphonates. British Journal of Clinical Pharmacology. PMID 30650219 DOI: 10.1111/Bcp.13867 |
0.319 |
|
| 2019 |
Sfeir J, Bedatsova L, Pena Guzman T, Broski S, Drake M. SAT-526 Use of Trabecular Bone Score for Risk Stratification of Patients with Monoclonal Gammopathy of Unknown Significance Journal of the Endocrine Society. 3. DOI: 10.1210/Js.2019-Sat-526 |
0.309 |
|
| 2019 |
Sfeir J, Bedatsova L, Guzman TP, Broski S, Drake M. Fracture Risk Assessment in Patients with Monoclonal Gammopathy of Undetermined Significance: Value of Bone Mineral Density and Trabecular Bone Score Clinical Lymphoma Myeloma and Leukemia. 19: e34-e35. DOI: 10.1016/J.Clml.2019.09.051 |
0.322 |
|
| 2018 |
Drake MT, Fenske JS, Blocki FA, Zierold C, Appelman-Dijkstra N, Papapoulos S, Khosla S. Validation of a novel, rapid, high precision sclerostin assay not confounded by sclerostin fragments. Bone. PMID 29550267 DOI: 10.1016/J.Bone.2018.03.013 |
0.301 |
|
| 2017 |
Farr JN, Xu M, Weivoda MM, Monroe DG, Fraser DG, Onken JL, Negley BA, Sfeir JG, Ogrodnik MB, Hachfeld CM, LeBrasseur NK, Drake MT, Pignolo RJ, Pirtskhalava T, Tchkonia T, et al. Targeting cellular senescence prevents age-related bone loss in mice. Nature Medicine. PMID 28825716 DOI: 10.1038/Nm.4385 |
0.324 |
|
| 2017 |
Drake MT, Collins MT, Hsiao EC. The Rare Bone Disease Working Group: report from the 2016 American Society for Bone and Mineral Research Annual Meeting. Bone. PMID 28115283 DOI: 10.1016/J.Bone.2017.01.021 |
0.302 |
|
| 2016 |
Elraiyah T, Ahmed AH, Wang Z, Farr JN, Murad MH, Drake MT. Predictors of teriparatide treatment failure in patients with low bone mass. Bone Reports. 4: 17-22. PMID 28326338 DOI: 10.1016/J.Bonr.2015.11.001 |
0.307 |
|
| 2016 |
Drake MT, Khosla S. Hormonal and systemic regulation of sclerostin. Bone. PMID 27965160 DOI: 10.1016/J.Bone.2016.12.004 |
0.309 |
|
| 2016 |
Farr JN, Fraser DG, Wang H, Jaehn K, Ogrodnik MB, Weivoda MM, Drake MT, Tchkonia T, LeBrasseur NK, Kirkland JL, Bonewald LF, Pignolo RJ, Monroe DG, Khosla S. Identification of Senescent Cells in the Bone Microenvironment. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 27341653 DOI: 10.1002/Jbmr.2892 |
0.307 |
|
| 2015 |
Nicks KM, Fujita K, Fraser D, McGregor U, Drake MT, McGee-Lawrence ME, Westendorf JJ, Monroe DG, Khosla S. Deletion of Estrogen Receptor Beta in Osteoprogenitor Cells Increases Trabecular but Not Cortical Bone Mass in Female Mice. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 26418452 DOI: 10.1002/Jbmr.2723 |
0.345 |
|
| 2015 |
Farr JN, Roforth MM, Fujita K, Nicks KM, Cunningham JM, Atkinson EJ, Therneau TM, McCready LK, Peterson JM, Drake MT, Monroe DG, Khosla S. Effects of Age and Estrogen on Skeletal Gene Expression in Humans as Assessed by RNA Sequencing. Plos One. 10: e0138347. PMID 26402159 DOI: 10.1371/Journal.Pone.0138347 |
0.34 |
|
| 2015 |
Drake MT, Clarke BL, Lewiecki EM. The Pathophysiology and Treatment of Osteoporosis. Clinical Therapeutics. 37: 1837-50. PMID 26163201 DOI: 10.1016/J.Clinthera.2015.06.006 |
0.352 |
|
| 2015 |
Roforth MM, Farr JN, Fujita K, McCready LK, Atkinson EJ, Therneau TM, Cunningham JM, Drake MT, Monroe DG, Khosla S. Global transcriptional profiling using RNA sequencing and DNA methylation patterns in highly enriched mesenchymal cells from young versus elderly women. Bone. 76: 49-57. PMID 25827254 DOI: 10.1016/J.Bone.2015.03.017 |
0.323 |
|
| 2014 |
Drake MT. unveiling skeletal fragility in patients diagnosed with MGUS: no longer a condition of undetermined significance? Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 29: 2529-33. PMID 25319751 DOI: 10.1002/Jbmr.2387 |
0.33 |
|
| 2014 |
Drake MT, Farr JN. Inhibitors of sclerostin: emerging concepts. Current Opinion in Rheumatology. 26: 447-52. PMID 24807403 DOI: 10.1097/Bor.0000000000000073 |
0.331 |
|
| 2014 |
Farr JN, Zhang W, Kumar SK, Jacques RM, Ng AC, McCready LK, Rajkumar SV, Drake MT. Altered cortical microarchitecture in patients with monoclonal gammopathy of undetermined significance. Blood. 123: 647-9. PMID 24227822 DOI: 10.1182/Blood-2013-05-505776 |
0.332 |
|
| 2014 |
Roforth MM, Fujita K, McGregor UI, Kirmani S, McCready LK, Peterson JM, Drake MT, Monroe DG, Khosla S. Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans. Bone. 59: 1-6. PMID 24184314 DOI: 10.1016/J.Bone.2013.10.019 |
0.322 |
|
| 2014 |
Fujita K, Roforth MM, Demaray S, McGregor U, Kirmani S, McCready LK, Peterson JM, Drake MT, Monroe DG, Khosla S. Effects of estrogen on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in postmenopausal women. The Journal of Clinical Endocrinology and Metabolism. 99: E81-8. PMID 24170101 DOI: 10.1210/Jc.2013-3249 |
0.332 |
|
| 2014 |
Lapid M, Kung S, Drake M, Cha S, Jankowski M, Frye M, Clarke B. EPA-0606 – Relationship between serotonin transporter and bone loss European Psychiatry. 29: 1. DOI: 10.1016/S0924-9338(14)77990-8 |
0.316 |
|
| 2013 |
Clarke BL, Drake MT. Clinical utility of serum sclerostin measurements. Bonekey Reports. 2: 361. PMID 24578825 DOI: 10.1038/Bonekey.2013.95 |
0.315 |
|
| 2013 |
Drake MT. Osteoporosis and cancer. Current Osteoporosis Reports. 11: 163-70. PMID 23877475 DOI: 10.1007/S11914-013-0154-3 |
0.3 |
|
| 2013 |
Ng AC, Melton LJ, Atkinson EJ, Achenbach SJ, Holets MF, Peterson JM, Khosla S, Drake MT. Relationship of adiposity to bone volumetric density and microstructure in men and women across the adult lifespan. Bone. 55: 119-25. PMID 23428401 DOI: 10.1016/J.Bone.2013.02.006 |
0.3 |
|
| 2012 |
Drake MT, Murad MH, Mauck KF, Lane MA, Undavalli C, Elraiyah T, Stuart LM, Prasad C, Shahrour A, Mullan RJ, Hazem A, Erwin PJ, Montori VM. Risk factors for low bone mass-related fractures in men: A systematic review and meta-analysis Journal of Clinical Endocrinology and Metabolism. 97: 1861-1870. PMID 22466344 DOI: 10.1210/Jc.2011-3058 |
0.302 |
|
| 2012 |
Zhang W, Drake MT. Potential role for therapies targeting DKK1, LRP5, and serotonin in the treatment of osteoporosis. Current Osteoporosis Reports. 10: 93-100. PMID 22210558 DOI: 10.1007/S11914-011-0086-8 |
0.372 |
|
| 2011 |
Ng AC, Khosla S, Charatcharoenwitthaya N, Kumar SK, Achenbach SJ, Holets MF, McCready LK, Melton LJ, Kyle RA, Rajkumar SV, Drake MT. Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1α levels in patients with MGUS. Blood. 118: 6529-34. PMID 22042700 DOI: 10.1182/Blood-2011-04-351437 |
0.334 |
|
| 2011 |
Drake MT, Srinivasan B, Mödder UI, Ng AC, Undale AH, Roforth MM, Peterson JM, McCready LK, Riggs BL, Khosla S. Effects of intermittent parathyroid hormone treatment on osteoprogenitor cells in postmenopausal women. Bone. 49: 349-55. PMID 21600325 DOI: 10.1016/J.Bone.2011.05.003 |
0.344 |
|
| 2010 |
Drake MT, McCready LK, Hoey KA, Atkinson EJ, Khosla S. Effects of suppression of follicle-stimulating hormone secretion on bone resorption markers in postmenopausal women. The Journal of Clinical Endocrinology and Metabolism. 95: 5063-8. PMID 20610587 DOI: 10.1097/Ogx.0B013E318227Fcbf |
0.323 |
|
| 2010 |
Drake MT, Cremers SC. Bisphosphonate therapeutics in bone disease: the hard and soft data on osteoclast inhibition. Molecular Interventions. 10: 141-52. PMID 20539033 DOI: 10.1124/Mi.10.3.5 |
0.339 |
|
| 2010 |
Undale A, Srinivasan B, Drake M, McCready L, Atkinson E, Peterson J, Riggs BL, Amin S, Modder UI, Moedder UI, Khosla S. Circulating osteogenic cells: characterization and relationship to rates of bone loss in postmenopausal women. Bone. 47: 83-92. PMID 20362080 DOI: 10.1016/J.Bone.2010.03.018 |
0.307 |
|
| 2009 |
Kennel KA, Drake MT. Adverse effects of bisphosphonates: implications for osteoporosis management. Mayo Clinic Proceedings. 84: 632-7; quiz 638. PMID 19567717 DOI: 10.4065/84.7.632 |
0.341 |
|
| 2009 |
Drake MT, Rajkumar SV. Effects of bortezomib on bone disease in multiple myeloma. American Journal of Hematology. 84: 1-2. PMID 19030185 DOI: 10.1002/Ajh.21324 |
0.355 |
|
| 2008 |
Drake MT, Clarke BL, Khosla S. Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clinic Proceedings. 83: 1032-45. PMID 18775204 DOI: 10.4065/83.9.1032 |
0.328 |
|
| 2008 |
Lee I, Drake MT, Traub LM, Kornfeld S. Cargo-sorting signals promote polymerization of adaptor protein-1 in an Arf-1.GTP-independent manner. Archives of Biochemistry and Biophysics. 479: 63-8. PMID 18762162 DOI: 10.1016/J.Abb.2008.08.009 |
0.518 |
|
| 2008 |
Drake MT, Violin JD, Whalen EJ, Wisler JW, Shenoy SK, Lefkowitz RJ. beta-arrestin-biased agonism at the beta2-adrenergic receptor. The Journal of Biological Chemistry. 283: 5669-76. PMID 18086673 DOI: 10.1074/Jbc.M708118200 |
0.744 |
|
| 2007 |
Wisler JW, DeWire SM, Whalen EJ, Violin JD, Drake MT, Ahn S, Shenoy SK, Lefkowitz RJ. A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling. Proceedings of the National Academy of Sciences of the United States of America. 104: 16657-62. PMID 17925438 DOI: 10.1073/Pnas.0707936104 |
0.685 |
|
| 2006 |
Drake MT, Shenoy SK, Lefkowitz RJ. Trafficking of G protein-coupled receptors. Circulation Research. 99: 570-82. PMID 16973913 DOI: 10.1161/01.Res.0000242563.47507.Ce |
0.675 |
|
| 2006 |
Shenoy SK, Drake MT, Nelson CD, Houtz DA, Xiao K, Madabushi S, Reiter E, Premont RT, Lichtarge O, Lefkowitz RJ. beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor. The Journal of Biological Chemistry. 281: 1261-73. PMID 16280323 DOI: 10.1074/Jbc.M506576200 |
0.744 |
|
| 2001 |
Zhu Y, Drake MT, Kornfeld S. Adaptor protein 1-dependent clathrin coat assembly on synthetic liposomes and Golgi membranes. Methods in Enzymology. 329: 379-87. PMID 11210557 DOI: 10.1016/S0076-6879(01)29099-5 |
0.508 |
|
| 2001 |
Drake MT, Zhu Y, Kornfeld S. The assembly of AP-3 adaptor complex-containing clathrin-coated vesicles on synthetic liposomes. Molecular Biology of the Cell. 11: 3723-36. PMID 11071902 DOI: 10.1091/Mbc.11.11.3723 |
0.506 |
|
| 1999 |
Zhu Y, Drake MT, Kornfeld S. ADP-ribosylation factor 1 dependent clathrin-coat assembly on synthetic liposomes. Proceedings of the National Academy of Sciences of the United States of America. 96: 5013-8. PMID 10220410 DOI: 10.1073/Pnas.96.9.5013 |
0.503 |
|
| 1997 |
Iida-Klein A, Guo J, Takemura M, Drake MT, Potts JT, Abou-Samra A, Bringhurst FR, Segre GV. Mutations in the second cytoplasmic loop of the rat parathyroid hormone (PTH)/PTH-related protein receptor result in selective loss of PTH-stimulated phospholipase C activity. The Journal of Biological Chemistry. 272: 6882-9. PMID 9054374 DOI: 10.1074/Jbc.272.11.6882 |
0.342 |
|
| 1994 |
Drake MT, Baldassare JJ, McConkey CL, Gonzalez EA, Martin KJ. Parathyroid hormone increases the expression of receptors for epidermal growth factor in UMR 106-01 cells Endocrinology. 134: 1733-1737. PMID 8137737 DOI: 10.1210/Endo.134.4.8137737 |
0.343 |
|
| Show low-probability matches. |